Skip to main content
Older man taking medication Getty Images 1496145218
ABSTRACT & COMMENTARY

Indications for Reduced-Dose Direct Oral Anticoagulants

A subgroup analysis of the ENGAGE-AF TIMI 48 study of edoxaban 60 mg/day vs. 30 mg/day compared to warfarin in patients with atrial fibrillation of the group 80 years of age or older has shown that 30 mg/day results in less major bleeding without a concomitant increase in stroke risk compared to 60 mg/day or warfarin.